Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort. (2018)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jpba.2018.06.062
PubMed Identifier: 30005242
Publication URI: http://europepmc.org/abstract/MED/30005242
Type: Journal Article/Review
Volume: 159
Parent Publication: Journal of pharmaceutical and biomedical analysis
ISSN: 0731-7085